PubHawk
BMC Infect Dis May 2024 PMID 38783176

Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial.

Toshio Inui, Oksana Kruglova, Olga Martynenko, Kostiantyn Martynenko, Vadym Tieroshyn, Anatoliy Gavrylov, Kentaro Kubo, Hajime Yamakage, Borys Kutsyn, Alla Kubashko, Zoryana Veklych, Yurika Terashima, Martin Mette, Galyna Kutsyna

Full text PDF Download social card

Mentions

12
Peak: 2 in May 2023
across 6 sources since May 2023

Extended reach

1,102
potential audience

Total likes

4

Video views

96

Mentions per month

May 2023 – Oct 2025

Where it's discussed

  • Instagram3 posts
  • X / Twitter2 posts
  • YouTube2 videos
  • Facebook2 posts
  • News2 articles
  • Blogs1 articles

AI synopsis

What people are saying

Discussions highlight the promising results, such as improvements in lymphocyte recovery and reduced mortality, with some posts noting the potential for these formulations to change treatment strategies, using words like 'significant' and 'breakthroughs' to underscore their perceived importance. The tone combines cautious optimism and scientific curiosity, emphasizing the clinical relevance of the study.

AgreementModerate agreement

Most discussions recognize the potential benefits of the study, indicating general agreement with its findings on improved clinical outcomes.

InterestModerate interest

Participants show moderate curiosity, often referencing the study’s focus on immune modulation and recovery in COVID-19 patients.

EngagementModerate engagement

Comments include mentions of immune responses, clinical implications, and the significance of the formulations, suggesting thoughtful engagement.

ImpactModerate impact

There is a consensus that these findings could influence COVID-19 treatment approaches, reflecting a perceived meaningful impact.

Abstract in brief

  • The study tested whether degalactosylated bovine glycoprotein formulations (MAF and M) can improve outcomes in hospitalized COVID-19 patients by targeting gut mucosal immunity to reduce inflammation.
  • Patients receiving MAF or M formulations showed faster recovery times and lower mortality rates compared to standard care, especially among those with low baseline lymphocyte counts, with improvements linked to better lymphocyte recovery.
  • The research suggests that these formulations may help restore lymphocyte levels, reduce lymphopenia-associated mortality, and improve overall clinical outcomes in COVID-19 patients by modulating immune responses.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Research Square Covid-19 Preprints
@RS_COVID19 · X

Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized Covid-19 patients: a randomized clinical trial #covid https://t.co/hJOcd8LaeB

May 10, 2023 · 1 like · 1 share · 638 followers View post →
AnotherLC
@0hffs999 · X

RT @RS_COVID19: Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hosp…

May 10, 2023 · 1 share · 285 followers View post →

All mentions

AnotherLC
@0hffs999 · X

RT @RS_COVID19: Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hosp…

May 10, 2023 · 1 share · 285 followers View post →
Research Square Covid-19 Preprints
@RS_COVID19 · X

Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized Covid-19 patients: a randomized clinical trial #covid https://t.co/hJOcd8LaeB

May 10, 2023 · 1 like · 1 share · 638 followers View post →
New Study Finds Degalactosylated Whey Protein Enhances ...
News

... 10.1186/s12879-024-09286-0 □Nutrients The Effects of Dietary Intervention and Macrophage-Activating Factor Supplementation on Cognitive ...

Mar 26, 2025 View →
新しいアンチエイジングの時代へようこそ！食品 MAFは、たった6か ...
Instagram

com/article/10.1186/s12879-024-09286-0 □Science Direct 「COVID- 19肺炎で入院中の患者における経口MAFの補助的使用が病状 進行および死亡率に ...

Dec 3, 2024 View →
Have you read our four published articles? This is our article on ...
Instagram

... 10.1186/s12879-024-09286-0 □Science Direct Adjunctive use of oral MAF is associated with no disease progression or mortality in ...

Nov 20, 2024 View →
Findings on Macrophage Activating Factor's Impact on Telomere ...
News

https://link.springer.com/article/10.1186/s12879-024-09286-0 □Nutrients The Effects of Dietary Intervention and Macrophage-Activating ...

Sep 27, 2024 View →
Our four published articles. frontiers Degalactosylated Whey Protein ...
Facebook

com/article/10.1186/s12879-024-09286-0 □Science Direct Adjunctive use of oral MAF is associated with no disease progression or mortality in ...

Aug 1, 2024 View →
こちらの４つの記事はお読み頂けましたでしょうか？ Nutrients ...
Facebook

com/article/10.1186/s12879-024-09286-0 □Science Direct 「COVID- 19肺炎で入院中の患者における経口MAFの補助的使用 が病状進行および死亡率に ...

Jul 30, 2024 View →
こちらの４つの記事はお読み頂けましたでしょうか？ Nutrients ...
Instagram

... 10.1186/s12879-024-09286-0 □Science Direct 「COVID-19肺炎で入院中の患者における経口MAFの補助的使用が病状進行および死亡率に影響を及ぼさない ...

Jul 30, 2024 View →
Stimulating Gut Mucosal Immunity Improves Outcomes in ...
Blogs

Source: bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-024-09286-0. Related Posts. NMBA-Related Perioperative Anaphylaxis Exceeds ...

May 31, 2024 View →